References
- Chou R, Fanciullo GJ, Fine PG, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10:113–130.
- Substance Abuse and Mental Health Services Administration. Results from the 2012 national survey on drug use and health: summary of national findings, NSDUH Series H-46. HHS Publication No. (SMA) 13-4795. [cited 2014 August 6]. Available from: http://www.samhsa.gov/data/sites/default/files/NSDUHnationalfindingresults2012/NSDUHnationalfindingresults2012/NSDUHresults2012.pdf
- Centers for Disease Control and Prevention. Vital signs: overdoses of prescription opioid pain relievers–United States, 1999–2008. MMWR Morb Mortal Wkly Rep. 2011;60:1487–1492.
- Substance Abuse and Mental Health Services Administration. The DAWN (Report June 18, 2010): trends in emergency department visits involving nonmedical use of narcotic pain relievers. [cited 2014 August 6]. Available from: http://www.ibhinc.org/pdfs/TrendsinEmergencyDepartmentVisitsInvolvingNonmedicalUseofNarcoticPainRelievers.pdf
- Jones CM, Mack KA, Paulozzi LJ. Pharmaceutical overdose deaths, United States, 2010. JAMA. 2013;309:657–659.
- Bronstein K, Passik S, Munitz L, et al. Predicting abnormal urine drug testing in patients on chronic opioid therapy. PAINWeek. Las Vegas (NV); 2010. [cited 2016 October 10]. Available from: http://www.painweek.org/scientificposters/2010-accepted-abstracts.html
- Gourlay DL, Heit HA. Universal precautions revisited: managing the inherited pain patient. Pain Med. 2009;10:S115–S123.
- Gourlay DL, Heit HA, Almahrezi A. Universal precautions in pain medicine: a rational approach to the treatment of chronic pain. Pain Med. 2005;6:107–112.
- Manchikanti L, Abdi S, Atluri S, et al. American society of interventional pain physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: part 2–guidance. Pain Physician. 2012;15:S67–116.
- Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain - United States, 2016. MMWR Recomm Rep. 2016;65:1–49.
- Butler SF, Budman SH, Fanciullo GJ, et al. Cross validation of the current opioid misuse measure to monitor chronic pain patients on opioid therapy. Clin J Pain. 2010;26:770–776.
- Butler SF, Budman SH, Fernandez KC, et al. Development and validation of the current opioid misuse measure. Pain. 2007;130:144–156.
- Butler SF, Fernandez K, Benoit C, et al. Validation of the revised screener and opioid assessment for patients with pain (SOAPP-R). J Pain. 2008;9:360–372.
- Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the opioid risk tool. Pain Med. 2005;6:432–442.
- Setnik B, Roland CL, Sommerville KW, et al. A multicenter, primary-care-based, open-label study to identify behaviors related to prescription opioid misuse, abuse, and diversion in opioid-experienced patients with chronic moderate-to-severe pain. J Pain Res. 2015;8:361–373.
- Passik SD, Kirsh KL, Casper D. Addiction-related assessment tools and pain management: instruments for screening, treatment planning, and monitoring compliance. Pain Med. 2008;9:S145–S166.
- Brown J, Setnik B, Lee K, et al. Effectiveness and safety of morphine sulfate extended-release capsules in patients with chronic, moderate-to-severe pain in a primary care setting. J Pain Res. 2011;4:373–384.
- Setnik B, Roland CL, Sommerville KW, et al. A multicenter, primary–care–based, open-label study to assess the success of converting opioid-experienced patients with chronic moderate-to-severe pain to morphine sulfate and naltrexone hydrochloride extended-release capsules using a standardized conversion guide. J Pain Res. 2015;8:347–360.
- Brown J, Setnik B, Lee K, et al. Assessment, stratification, and monitoring of the risk for prescription opioid misuse and abuse in the primary care setting. J Opioid Manag. 2011;7:467–483.
- Smith SM, Dart RC, Katz NP, et al. Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendations. Pain. 2013;154:2287–2296.